Petros Pharmaceuticals, Inc. SEC filings PTPI

Petros Pharmaceuticals, Inc. has 257 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (bankruptcy, officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
DEF 14A Proxy statement Mar 18, 2025 Apr 10, 2025
PRE 14A Preliminary proxy statement Mar 7, 2025 Mar 7, 2025
DEFA14A Additional proxy material Nov 18, 2024 —
DEF 14A Proxy statement Oct 25, 2024 Nov 20, 2024
PRE 14A Preliminary proxy statement Oct 15, 2024 Nov 20, 2024
DEF 14A Proxy statement Nov 30, 2023 Dec 29, 2023
DEF 14A Proxy statement Aug 25, 2023 Sep 14, 2023
PRE 14A Preliminary proxy statement Aug 15, 2023 Sep 14, 2023
DEFA14A Additional proxy material Oct 12, 2022 —
DEF 14A Proxy statement Oct 12, 2022 Nov 29, 2022
PRE 14A Preliminary proxy statement Sep 30, 2022 Sep 30, 2022
DEF 14A Proxy statement Nov 22, 2021 Dec 22, 2021

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTPI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1815903

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.